Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease

Brain

Volumn 124, Issue 4, 2001, Pages 784-792

  Ouchi, Yasuomi ^a   Kanno, Toshihiko ^a   Okada, Hiroyuki ^b   Yoshikawa, Etsuji ^b   Futatsubashi, Masami ^b   Nobezawa, Shuji ^a   Torizuka, Tatsuo ^a   Tanaka, Keisei ^a  

^a HAMAMATSU MEDICAL CENTER   (Japan)

^b CENTRAL RESEARCH LABORATORY   (Japan)

Author keywords

Dopamine availability; Gait; Parkinson's disease; PET; Statistical parametric mapping

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; DOPAMINE; RADIOLIGAND;

ADULT; AGED; ARTICLE; BRAIN CORTEX; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; FEMALE; GAIT; HUMAN; MALE; NIGRONEOSTRIATAL SYSTEM; ORBITAL CORTEX; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN;

EID: 0035045612     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/124.4.784     Document Type: Article

References (47)

1. The functional anatomy of basal ganglia disorders
2. Functional architecture of basal ganglia circuits: Neural substrates of parallel processing
3. Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes
4. Structural evaluation of the prefrontal cortex in schizophrenia
5. Responses of striatal neurons in the behaving monkey. 2. Visual processing in the caudal neostriatum
6. Disinhibition as a basic process in the expression of striatal functions
7. Primate models of movement disorders of basal ganglia origin
8. Unified Parkinson's disease rating scale
9. Statistical parametric maps in functional imaging: A general linear approach
10. Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease
11. Brain functional activity during gait in normal subjects: A SPECT study
12. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons
13. Coupled forebrain increases of local cerebral glucose utilization and blood flow during physiologic stimulation of a somatosensory pathway in the rat: Demonstration by double-label autoradiography
14. Metabolic mapping of functional activity in human subjects with the [18F]fluorodeoxyglucose technique
15. Mechanisms underlying gait disturbance in Parkinson's disease: Single photon emission computed tomography study
16. Striatal dopamine turnover during treadmill running in the rat: Relation to the speed of running
17. Nigrostriatal dopaminergic activity is increased during exhaustive exercise stress in rats
18. Effects of dopamine on postural control in parkinsonian subjects: Scaling, set, and tone
19. Brian function associated with bipedal gait - A PET study
20. Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease
21. Loss of autoreceptor functions in mice lacking the dopamine transporter
22. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications
23. Evidence for striatal dopamine release during a video game
24. Bilateral projections from precentral motor cortex to the putamen and other parts of the basal ganglia. An autoradiographic study in Macaca fascicularis
25. An autoradiographic analysis of the efferent connections from premotor and adjacent prefrontal regions (areas 6 and 9) in macaca fascicularis
26. The mysterious motor function of the basal ganglia: The Robert Wartenberg Lecture
27. Basal ganglia motor control. I. Nonexclusive relation of pallidal discharge to five movement modes
28. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography
29. Cerebellar activation during ataxic gait in olivopontocerebellar atrophy: A PET study
30. Cholecystokinin- and dopamine-containing mesencephalic neurons provide distinct projections to monkey prefrontal cortex
31. Altered glucose metabolism in the hippocampal head in memory impairment
32. Brain activation during maintenance of standing postures in humans
33. Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: Compartment analysis for beta-CFT binding with positron emission tomography
34. Extrinsic connections of the basal ganglia
35. Brainstem innervation of prefrontal and anterior cingulate cortex in the rhesus monkey revealed by retrograde transport of HRP
36. Responses of striatal neurons in the behaving monkey. 1. Head of the caudate nucleus
37. Dopamine deficiency in the cerebral cortex in Parkinson disease
38. Effect of dopaminergic drugs on the in vivo binding of [3H]WIN 35,428 to central dopamine transporters
39. Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task
40. Organization of the ascending striatal afferents in monkeys
41. Selective activation of mesocortical DA system by stress
42. Parkinson's disease: Loss of neurons from the ventral tegmental area contralateral to therapeutic surgical lesions
43. Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: Evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations
44. In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428
45. Development of a high resolution PET